LATEST NEWS

Newly discovered biological switch evolved to stimulate the immune system—can also lead to immune paralysis
Their analysis provides essential information for vaccine design and the evaluation of diagnostics and vaccine candidates
Former AMCC Chair and CEO David M. Rickey joins Institute Board
Foley & Lardner partner J. Mark Waxman joins Institute Board
The proposed iMAP will reveal new targets for immunotherapy, and may lead to a new wave of medicines and vaccines that can prevent heart attacks and strokes; La Jolla Institute for Immunology researcher Klaus Ley and Scripps researcher Eric Topol are key members of the iMAP team.
Sometimes it takes a personal health crisis to galvanize people to pursue a life-changing path they could have never envisioned.
The finding is important to both the basic understanding of this disease—the world’s most common mosquito-borne illness—and to the hunt for an effective vaccine for dengue.
The Beacon optofluidic technology will be used to speed the identification of lifesaving treatments for deadly viruses including Ebola, Lassa and others.
Based on its history, HMCES could be the most important protein you've never heard of
Professors Shane Crotty, Ph.D., and Alessandro Sette, Dr. Biol.Sci., of La Jolla Institute for Immunology have been named as AAAS Fellows
This year’s list features four scientists at La Jolla Institute for Immunology